1093310

Novocol Pharmaceutical of Canada, Inc. — FEI 3002807757

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 18, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cambridge (Canada)

Citations

IDCFRDescription
145121 CFR 211.113(b)Procedures for sterile drug products